Neurogene Inc. Other Non-Current Liabilities
Neurogene Inc. (NGNE) had Other Non-Current Liabilities of $0 as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-11
- 2026-06-30: Other Liabilities, Noncurrent $0.00.
- 2026-03-31: Other Liabilities, Noncurrent $0.00.
- 2025-12-31: Other Liabilities, Noncurrent $51.00K.
- 2025-09-30: Other Liabilities, Noncurrent $51.00K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-11 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-12 |
| 2025-12-31 | $51.00K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $51.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $51.00K 10-Q · filed 2025-08-11 |
| 2025-03-31 | $51.00K 10-Q · filed 2025-05-09 |
| 2024-12-31 | $51.00K 10-K · filed 2026-03-24 |
| 2024-09-30 | $51.00K 10-Q · filed 2024-11-18 |
| 2024-06-30 | $51.00K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $203.00K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $203.00K 10-K · filed 2025-03-24 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-18 |
| 2019-06-30 | $2.00K 10-Q · filed 2019-08-01 |
| 2019-03-31 | $4.00K 10-Q · filed 2019-05-07 |
| 2018-12-31 | $319.00K 10-Q · filed 2019-08-01 |
| 2018-09-30 | $343.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $401.00K 10-Q · filed 2018-08-08 |
| 2018-03-31 | $443.00K 10-Q · filed 2018-05-08 |
| 2017-12-31 | $486.00K 10-K · filed 2019-03-07 |
| 2017-09-30 | $513.00K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $548.00K 10-Q · filed 2017-08-08 |
| 2017-03-31 | $562.00K 10-Q · filed 2017-05-09 |
| 2016-12-31 | $197.00K 10-K · filed 2018-03-12 |
| 2016-09-30 | $142.00K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $114.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $106.00K 10-Q · filed 2016-05-10 |
| 2015-12-31 | $131.00K 10-K · filed 2017-03-09 |
| 2014-12-31 | $72.00K 10-K · filed 2016-03-14 |
| 2014-03-31 | $7.05K 10-Q · filed 2014-05-13 |
| 2013-12-31 | $8.56K 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |